Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies

Title
Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies
Authors
Keywords
Post-transplant lymphoproliferative disease, PTLD, Lymphoma, Non-Hodgkin lymphoma, Hodgkin lymphoma, Central nervous system, CNS, Lymphoma, Epidemiology, Risk factors, Diagnosis, Pathogenesis, Genetic variation, EBV, LMP2A, Prognosis, Treatment, Rituximab, Adoptive immunotherapy, Chemotherapy
Journal
Current Hematologic Malignancy Reports
Volume 8, Issue 3, Pages 173-183
Publisher
Springer Nature
Online
2013-06-04
DOI
10.1007/s11899-013-0162-5

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started